ArticleRheumatology and therapy2025

A Comparison of the Immunogenicity of Intravenous BAT1806, a Tocilizumab Biosimilar, and Its Reference Product.

Hans C Ebbers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.